Lee Kang Hong, Kim Hee Cheol, Yu Chang Sik, Myung Seung Jae, Yang Suk Gyun, Kim Jin Cheon
Department of Surgery, Hanyang University College of Medicine, Seoul, Korea.
Korean J Gastroenterol. 2005 Nov;46(5):381-7.
BACKGROUND/AIMS: Guidelines for current postoperative colonoscopic surveillance are not specified in colorectal cancer (CRC) patients with synchronous adenoma (SA). We performed this retrospective study to determine the postoperative colonoscopic surveillance interval for the CRC patients with SA.
One hundred and twenty-four CRC patients with SA (SA-group) and the same number of patients without SA (NSA-group) were selected from our database. Two groups were matched by the stage of CRC. Median colonoscopic surveillance period was 55 (12-99) months. The colonoscopic surveillance frequency and interval were similar between the two groups.
Mean age was higher and male was more frequent in SA-group than NSA-group (p= 0.0001). The incidence of missed adenoma, advanced missed adenoma and metachronous adenoma (MA) were higher in SA-group (30.8% vs. 5.8% at 1st yr., p=0.0001; 4.4% vs. 0%, p=0.0001; 31.1% vs. 9.1% at 2nd yr., p=0.016) during the first consecutive two years of surveillance. The MA- and advanced-MA-free survival rate were lower in SA-group (24.6% vs. 6.6%, p=0.0001; 4.1% vs. 0%, p=0.02) during three years after surgery. Dysplasia of the SA (p=0.04; OR, 110.3; 95% CI, 1.13-10742.6) and presence of missed adenoma (p=0.036; OR, 43.6; 95% CI, 1.28-1490.1) were risk factors for the advanced MA on a multivariate analysis in SA-group.
Postoperative colonoscopic surveillance at first year after surgery is warranted in CRC patients with SA.
背景/目的:目前对于患有同步腺瘤(SA)的结直肠癌(CRC)患者,术后结肠镜监测的指南尚未明确。我们开展这项回顾性研究以确定患有SA的CRC患者术后结肠镜监测的间隔时间。
从我们的数据库中选取124例患有SA的CRC患者(SA组)以及相同数量无SA的患者(非SA组)。两组按CRC分期进行匹配。结肠镜监测的中位时间为55(12 - 99)个月。两组的结肠镜监测频率和间隔相似。
SA组的平均年龄高于非SA组,男性更为常见(p = 0.0001)。在连续监测的头两年中,SA组漏诊腺瘤、高级别漏诊腺瘤和异时性腺瘤(MA)的发生率更高(第1年分别为30.8%对5.8%,p = 0.0001;4.4%对0%,p = 0.0001;第2年分别为31.1%对9.1%,p = 0.016)。术后三年中,SA组无MA和无高级别MA的生存率较低(分别为24.6%对6.6%,p = 0.0001;4.1%对0%,p = 0.02)。在SA组的多因素分析中,SA的发育异常(p = 0.04;OR,110.3;95%CI,1.13 - 10742.6)和漏诊腺瘤的存在(p = 0.036;OR,43.6;95%CI,1.28 - 1490.1)是高级别MA的危险因素。
患有SA的CRC患者术后第一年有必要进行结肠镜监测。